Clinical Trial Update: Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for Temsirolimus and Perifosine in recurrent or progressive malignant glioma (Phase 1/2) with completed status and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anaplastic Astrocytoma
• Anaplastic Oligodendroglioma
• Brain Neoplasm
• Diffuse Astrocytoma
• Giant Cell Glioblastoma
• Glioblastoma
• Gliosarcoma
• Mixed Glioma
• Oligodendroglioma

Drugs mentioned

• Perifosine (perifosine)
• Temsirolimus (temsirolimus)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2016-04-18